Literature DB >> 19179049

Long-term stability of measuring D(2) receptors in schizophrenia patients treated with antipsychotics.

Hiroyuki Uchida1, Ariel Graff-Guerrero, Benoit H Mulsant, Bruce G Pollock, David C Mamo.   

Abstract

BACKGROUND: While antipsychotic-free schizophrenia patients showed a high degree of within-subject variability in dopamine D(2) receptor density over 6-24 months, no study has examined the long-term stability of D(2) receptor measures in medicated patients.
METHODS: Four schizophrenia patients receiving a stable dose of risperidone underwent [(11)C]raclopride positron emission tomography scans on two occasions 5-14 months apart.
RESULTS: Plasma risperidone levels were found to be consistent between scans, and consistencies of nondisplaceable D(2) binding potential and D(2) occupancy were good.
CONCLUSIONS: The finding supports the validity of quantification of D(2) receptor binding in longitudinal PET studies of medicated patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179049     DOI: 10.1016/j.schres.2008.12.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial.

Authors:  Shinichiro Nakajima; Hiroyuki Uchida; Robert R Bies; Fernando Caravaggio; Takefumi Suzuki; Eric Plitman; Wanna Mar; Philip Gerretsen; Bruce G Pollock; Benoit H Mulsant; David C Mamo; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

Review 2.  Sensitivity to antipsychotic drugs in older adults.

Authors:  Chloe Leon; Philip Gerretsen; Hiroyuki Uchida; Takefumi Suzuki; Tarek Rajji; David C Mamo
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

3.  Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.

Authors:  Takefumi Suzuki; Ariel Graff-Guerrero; Hiroyuki Uchida; Gary Remington; Fernando Caravaggio; Carol Borlido; Bruce Pollock; Benoit Mulsant; Vincenzo Deluca; Zahinoor Ismail; David Mamo
Journal:  Psychopharmacology (Berl)       Date:  2013-02-17       Impact factor: 4.530

4.  Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.

Authors:  Aine M Duffy; Megan L Fitzgerald; June Chan; Danielle C Robinson; Teresa A Milner; Kenneth Mackie; Virginia M Pickel
Journal:  Synapse       Date:  2011-12       Impact factor: 2.562

5.  Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Authors:  Ursula F Bailer; Guido K Frank; Julie C Price; Carolyn C Meltzer; Carl Becker; Chester A Mathis; Angela Wagner; Nicole C Barbarich-Marsteller; Cinnamon S Bloss; Karen Putnam; Nicholas J Schork; Anthony Gamst; Walter H Kaye
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

6.  Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later.

Authors:  Samuel Asensio; Maria J Romero; Francisco J Romero; Christopher Wong; Nelly Alia-Klein; Dardo Tomasi; Gene-Jack Wang; Frank Telang; Nora D Volkow; Rita Z Goldstein
Journal:  Synapse       Date:  2010-05       Impact factor: 2.562

Review 7.  The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.

Authors:  Philip Gerretsen; Daniel J Müller; Arun Tiwari; David Mamo; Bruce G Pollock
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.